FONAR Corporation logo
FONAR Corporation FONR
$ 18.49 -0.38%

Quarterly report 2025-Q4
added 02-13-2026

report update icon

FONAR Corporation Operating Income 2011-2026 | FONR

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula
Operating profit = Revenue – Operating expenses
Features of the metric
  • Evaluates business efficiency
    Shows how well the company controls its production and administrative costs.
  • Independent of financial structure
    Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
  • Main source for growth
    High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income FONAR Corporation

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
5.31 M -7.09 M - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
5.31 M -7.09 M -892 K

Operating Income of other stocks in the Medical devices industry

Issuer Operating Income Price % 24h Market Cap Country
Aziyo Biologics Aziyo Biologics
AZYO
-30.5 M - 1.37 % $ 20.5 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
253 M $ 39.08 -1.83 % $ 5.82 K usaUSA
Conformis Conformis
CFMS
-46.3 M - - $ 16.4 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
-35.8 M - 0.15 % $ 844 M usaUSA
Cutera Cutera
CUTR
-156 M - -10.19 % $ 1.99 M usaUSA
Acutus Medical Acutus Medical
AFIB
-11.7 M - -26.83 % $ 2.62 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
-2.45 M - 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
-112 M - - $ 10.2 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
-1.27 M - 3.58 % $ 2.21 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
-24.7 M - -0.97 % $ 54.4 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
-5.13 M $ 7.79 3.73 % $ 559 M israelIsrael
AdaptHealth Corp. AdaptHealth Corp.
AHCO
90.9 M $ 9.41 -2.39 % $ 1.27 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
-31.4 M - - $ 475 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
103 M $ 43.34 -5.35 % $ 1.35 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
-10 M $ 1.45 2.84 % $ 23.4 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
22 M $ 104.65 0.88 % $ 1.33 B usaUSA
Avinger Avinger
AVGR
-16.6 M - -20.74 % $ 369 K usaUSA
AxoGen AxoGen
AXGN
-7.85 M $ 29.78 -2.84 % $ 1.37 B usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
-17.3 M $ 3.18 -3.05 % $ 110 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
-64.9 M - - $ 3.31 B usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
7.84 M $ 0.52 -5.19 % $ 53.4 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
-57.7 M $ 1.53 - $ 59.8 M usaUSA
Neovasc Neovasc
NVCN
-31.1 M - - $ 111 M canadaCanada
Medigus Ltd. Medigus Ltd.
MDGS
-9.9 M - 10.28 % $ 55.5 M israelIsrael
Medtronic PLC Medtronic PLC
MDT
5.96 B $ 96.73 -1.38 % $ 124 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
-16.8 M $ 0.79 5.78 % $ 43 M usaUSA
Align Technology Align Technology
ALGN
608 M $ 182.92 -3.23 % $ 13.7 B usaUSA
Inari Medical Inari Medical
NARI
-28.1 M - - $ 4.23 B usaUSA
Butterfly Network Butterfly Network
BFLY
-74.4 M $ 3.73 -3.37 % $ 790 M usaUSA
BIOLASE BIOLASE
BIOL
-17.9 M - -13.19 % $ 166 K usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
-20.5 M $ 3.96 -3.54 % $ 148 M franceFrance
Abbott Laboratories Abbott Laboratories
ABT
8.05 B $ 113.53 -0.49 % $ 198 B usaUSA
Nevro Corp. Nevro Corp.
NVRO
-126 M - - $ 217 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
-81.4 M $ 13.02 -2.62 % $ 516 M curacaoCuracao
BioSig Technologies BioSig Technologies
BSGM
-12.9 M - 37.08 % $ 85.7 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
3.61 B $ 73.88 -3.07 % $ 109 B usaUSA
PAVmed PAVmed
PAVM
-68.8 M $ 9.94 -0.4 % $ 71.9 M usaUSA
Penumbra Penumbra
PEN
189 M $ 340.23 -0.61 % $ 13.2 B usaUSA